ES2721180T3 - Productos terapéuticos usando células adiposas y secreciones celulares - Google Patents

Productos terapéuticos usando células adiposas y secreciones celulares Download PDF

Info

Publication number
ES2721180T3
ES2721180T3 ES12833860T ES12833860T ES2721180T3 ES 2721180 T3 ES2721180 T3 ES 2721180T3 ES 12833860 T ES12833860 T ES 12833860T ES 12833860 T ES12833860 T ES 12833860T ES 2721180 T3 ES2721180 T3 ES 2721180T3
Authority
ES
Spain
Prior art keywords
cells
adipose tissue
composition
tissue derived
secretions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12833860T
Other languages
English (en)
Spanish (es)
Inventor
Graham Vesey
Rebecca Anne Webster
Richard Lilischkis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Ideas Pty Ltd
Original Assignee
Cell Ideas Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011903938A external-priority patent/AU2011903938A0/en
Application filed by Cell Ideas Pty Ltd filed Critical Cell Ideas Pty Ltd
Application granted granted Critical
Publication of ES2721180T3 publication Critical patent/ES2721180T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
ES12833860T 2011-09-23 2012-09-21 Productos terapéuticos usando células adiposas y secreciones celulares Active ES2721180T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2011903938A AU2011903938A0 (en) 2011-09-23 Therapeutic methods and compositions
AU2012901350A AU2012901350A0 (en) 2012-04-04 Therapeutic methods and compositions
AU2012903646A AU2012903646A0 (en) 2012-08-23 Therapeutic methods and compositions
PCT/AU2012/001140 WO2013040649A1 (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions

Publications (1)

Publication Number Publication Date
ES2721180T3 true ES2721180T3 (es) 2019-07-29

Family

ID=47913679

Family Applications (2)

Application Number Title Priority Date Filing Date
ES12833860T Active ES2721180T3 (es) 2011-09-23 2012-09-21 Productos terapéuticos usando células adiposas y secreciones celulares
ES19153401T Active ES2880084T3 (es) 2011-09-23 2012-09-21 Terapias que usan células adiposas y secreciones celulares

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES19153401T Active ES2880084T3 (es) 2011-09-23 2012-09-21 Terapias que usan células adiposas y secreciones celulares

Country Status (9)

Country Link
US (3) US10111909B2 (enExample)
EP (3) EP2744892B1 (enExample)
JP (5) JP6162123B2 (enExample)
AU (1) AU2012313352B2 (enExample)
CA (1) CA2885487C (enExample)
DK (2) DK2744892T3 (enExample)
ES (2) ES2721180T3 (enExample)
SG (2) SG2014013676A (enExample)
WO (1) WO2013040649A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
AU2012313352B2 (en) * 2011-09-23 2015-07-02 Cell Ideas Pty Ltd Stem cells and secretions for treatment of inflammatory conditions
AU2013204930C1 (en) * 2012-09-26 2015-01-22 Cell Ideas Pty Ltd Therapeutics using multiple injections of cells
WO2014078705A1 (en) 2012-11-15 2014-05-22 Allosource Minced cartilage systems and methods
NZ629700A (en) 2012-12-24 2017-01-27 Cell Ideas Pty Ltd Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
CA2894750C (en) 2013-02-22 2021-12-14 Allosource Cartilage mosaic compositions and methods
WO2014151939A1 (en) 2013-03-15 2014-09-25 Allosource Perforated osteochondral allograft compositions
EP2970882B1 (en) 2013-03-15 2018-11-28 AlloSource Cell repopulated collagen matrix for soft tissue repair and regeneration
CA2915249C (en) * 2013-06-19 2022-04-12 Spinalcyte, Llc Adipose cells for chondrocyte applications
US20160245825A1 (en) 2013-10-04 2016-08-25 Cell Ideas Pty Ltd Biomarkers for Cell Therapy
US20180221411A1 (en) * 2014-12-19 2018-08-09 Cell Ideas Pty Ltd Improved Cell Therapies
KR20180043834A (ko) 2015-09-08 2018-04-30 셀 아이디어스 피티와이 엘티디 세포 신장 방법들 및 치료 조성물들
HK1254380A1 (zh) * 2015-11-24 2019-07-19 日本乐敦制药株式会社 包含脂肪组织来源基质细胞的肝病治疗剂及其制造方法
WO2018002930A1 (en) 2016-06-30 2018-01-04 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
AU2018270396B2 (en) 2017-05-15 2025-03-20 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells
CN110709091A (zh) 2017-05-15 2020-01-17 干细胞医药有限公司 使用长效格拉替雷和脂肪源性干细胞治疗多发性硬化症
CN110520137A (zh) * 2017-10-02 2019-11-29 福冈大太朗 用于头皮或皮肤的改质、创伤治愈或毛发的改质的药物组合物
WO2019238952A1 (en) * 2018-06-15 2019-12-19 Marinas Pardo Luis Pharmaceutical composition for dermatology and uses thereof
EP3838279B1 (en) * 2018-08-14 2025-03-05 National Center for Global Health and Medicine Supernatant of brown adipocytes, method for preparing same and utilization thereof
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
JP6826744B1 (ja) * 2020-07-17 2021-02-10 医療法人Ｙａｎａｇａ ＣＬｉｎｉｃ 成熟脂肪細胞含有組成物の製造方法
CN114452303B (zh) * 2020-11-10 2025-05-30 上海萨美细胞技术有限公司 无细胞脂肪提取液对关节炎的治疗用途
IT202100003062A1 (it) * 2021-02-11 2022-08-11 Gaia Margiotta "processo di crioconservazione di tessuto adiposo"
JP7057006B1 (ja) * 2021-04-12 2022-04-19 医療法人社団サカイクリニック６２ 歯周組織用製剤及びそれを含むキット
CN115521908A (zh) * 2022-10-24 2022-12-27 潍坊天创生物科技有限公司 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法
EP4638696A1 (en) 2022-12-27 2025-10-29 AVITA Medical Americas, LLC System for automated preparation of a regenerative epidermal suspension and related methods of use
CN118105463B (zh) * 2024-02-27 2025-05-30 上海萨美细胞技术有限公司 脂肪脱细胞活性蛋白在抗阿尔兹海默症中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
AU2002356935A1 (en) * 2001-11-09 2003-05-19 Artecel Sciences, Inc. Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
EP2305276A3 (en) * 2001-12-07 2011-09-21 Cytori Therapeutics, Inc. Processed lipoaspirate cells for use in therapy
SG146691A1 (en) * 2003-10-08 2008-10-30 Vet Stem Inc Methods of preparing and using stem cell compositions and kits comprising the same
US8715733B2 (en) * 2004-07-23 2014-05-06 DePuy Synthes Products, LLC Enhanced adipose tissue
JP5240715B2 (ja) * 2006-08-08 2013-07-17 国立大学法人名古屋大学 脂肪組織由来多分化能幹細胞を含有する細胞製剤
WO2008060374A2 (en) * 2006-10-06 2008-05-22 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
AU2009227022B2 (en) * 2008-03-19 2014-07-03 Cryo-Save Ag Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
US9144584B2 (en) 2008-06-11 2015-09-29 Cell4Vet Corporation Adipose tissue-derived stem cells for veterinary use
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
DK2425844T3 (da) * 2009-04-28 2014-06-16 Anterogen Co Ltd Autolog og allogen stromastamcellesammensætning, der stammer fra fedtvæv, til behandling af fistler
US20120201791A1 (en) 2009-10-15 2012-08-09 Tai June Yoo Methods of treating diseases or conditions using mesenchymal stem cells
US9730964B2 (en) * 2011-03-15 2017-08-15 Cell Ideas Pty Ltd. Pharmaceutical compositions and topical use thereof
AU2012313352B2 (en) * 2011-09-23 2015-07-02 Cell Ideas Pty Ltd Stem cells and secretions for treatment of inflammatory conditions

Also Published As

Publication number Publication date
EP2744892A4 (en) 2015-05-20
AU2012313352B2 (en) 2015-07-02
US20200261510A1 (en) 2020-08-20
JP7022863B2 (ja) 2022-02-18
EP3546569A1 (en) 2019-10-02
EP2744892B1 (en) 2019-03-20
EP3868871A1 (en) 2021-08-25
WO2013040649A1 (en) 2013-03-28
EP2744892A1 (en) 2014-06-25
EP3546569B1 (en) 2021-06-16
JP6912512B2 (ja) 2021-08-04
AU2012313352A9 (en) 2013-09-26
CA2885487A1 (en) 2013-03-28
US10111909B2 (en) 2018-10-30
CA2885487C (en) 2021-11-16
US20140234272A1 (en) 2014-08-21
ES2880084T3 (es) 2021-11-23
JP2019142971A (ja) 2019-08-29
JP6162123B2 (ja) 2017-07-12
SG10201606745XA (en) 2016-10-28
US10660921B2 (en) 2020-05-26
SG2014013676A (en) 2014-05-29
US20190015455A1 (en) 2019-01-17
JP6839038B2 (ja) 2021-03-03
JP2021155461A (ja) 2021-10-07
JP2022033865A (ja) 2022-03-02
DK3546569T3 (da) 2021-07-12
JP2017193566A (ja) 2017-10-26
JP2014527821A (ja) 2014-10-23
AU2012313352A1 (en) 2013-05-02
DK2744892T3 (en) 2019-04-23

Similar Documents

Publication Publication Date Title
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
BR112014031874A2 (pt) método para preparar células-tronco em concentração elevada
BR112013004917A2 (pt) terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais.
BR112015017174A2 (pt) preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico
NZ630598A (en) Method of engrafting cells from solid tissues
CO7151524A2 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciación y usos de los mismos
BR112014015417A2 (pt) diferenciação de células-tronco embrionárias humanas em células positivas de insulina hormonal únicas
EA201391154A3 (ru) Способы и композиции для нацеливания на адипоциты у млекопитающих
BR112013032659A2 (pt) método para o tratamento de células-tronco mesenquimais, que compreende a obtenção e o isolamento das células-tronco mesenquimais e a cultura das células em um meio de tratamento; células-tronco mesenquimais; e uso das células
CL2015002725A1 (es) Compuestos aromáticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepática, la fibrosis de la piel y la fibrosis cardíaca
ECSP13012869A (es) Compuestos y métodos para la modulación de quinasas e indicaciones para los mismos
JP2014527821A5 (enExample)
BR112015009229A2 (pt) composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada
BR112018069090A2 (pt) tratamento de câncer com base na distribuição de oligos por meio de junções comunicantes a partir de células estaminais mesenquimatosas humanas (hmsc)
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
CL2015003402A1 (es) Células madres adultas adiposas, humanas, pluripotentes: aislamiento, caracterización e implicaciones clinicas
CL2010000774A1 (es) Medio para el cultivo de celulas de mamiferos que comprende ademas de los nutrientes habituales de los medios de cultivo basales para cultivo de celulas de mamiferos, sobrenadante de la fraccion ii+iii del plasma humano segun el metodo de cohn; procedimiento de preparacion; y su uso.
BR112015000547A2 (pt) métodos para tratar tecido; e composição de tecido
UY34009A (es) ?uso de receptor de a2b adenosina para tratar la insuficiencia cardíaca y la arritmia en pacientes posinfarto de miocardio?.
JP2018501241A5 (enExample)
JP2012507997A5 (enExample)
ES2434853B1 (es) Marcador molecular de potencia terapéutica de células madre mesenquimales humanas y sus usos
PH12015502657A1 (en) Interactions of betanodaviruses in infection
AR110634A1 (es) Método para preparar un suplemento a partir de cultivos de células mesenquimales de gelatina de wharton y usos del mismo
Martinello et al. Comparison in vivo applications between peripheral blood-derived mesenchymal stromal cells (PB-MSCs) and platlet-rich plasma (PRP) in injured tendons of sheep